$BLLN

Atay Oguzhan sold $4.5M of BLLN

Atay Oguzhan (Chairman and CEO) sold 32,500 shares of BillionToOne, Inc. (BLLN) at an average of $136.95 ($133.00–$139.21, $4.45M total) across 21 trades on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Atay Oguzhan
Published Aug 6, 2026, 12:52 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 1:05 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BLLN
Neutral
medium confidence
Mentioned
$BLLN
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLLNNeutralLow
01

Why it matters

The disclosed event is an insider open-market sale by the CEO/Chairman, executed under a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

02

Market read

Traders may note the insider sale for sentiment, but there is no new fundamental catalyst (no guidance, trial, contract, or regulatory action).

03

What to watch

The article does not indicate whether other insiders or the company also made concurrent purchases, nor does it provide context on total insider holdings beyond the post-transaction zero shares.

Relevance 5/10Novelty 3/10Timing: filed Aug 5, transaction dated Aug 3

Background

The article is an SEC Form 4 insider transaction disclosure for BillionToOne, Inc.

Company-level read

Ticker impact

$BLLNNeutralMedium confidence
Context

BillionToOne CEO/Chairman Atay Oguzhan filed a Form 4 selling about 32,500 shares for roughly $4.45M at $133.00 to $139.21.

Expected impact

Likely minimal immediate price impact; any effect would be sentiment-driven and short-lived.

Evidence & confidence

The filing is a disclosed sale (not a purchase), explicitly tied to a pre-arranged 10b5-1 plan, and provides no new operating or financial guidance.

Market effects

No clear sector read-through; this is company-specific insider trading disclosure.

None.

None.

Counterpoint

Even with a 10b5-1 plan, large insider sales can coincide with periods of reduced confidence or liquidity needs, so some traders may still fade rallies.

Key entities

  • BillionToOne, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Atay Oguzhan

    Chairman and CEO who sold shares via an open-market transaction under a 10b5-1 plan.

Related articles

$BLLNMedAI 8/10

BillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Move - BillionToOne (NASDAQ:BLLN)

BillionToOne (NASDAQ:BLLN) shares fell 28.12% in after-hours after reporting Q2 results. For the quarter ended June 30, 2026, revenue rose to $109.4M from $66.6M, net income was $8.1M ($0.15/share), and gross margin improved to 70%. The company kept 2026 revenue guidance of $450M to $465M and plans Unity Fetal Risk Screen (Aug. 17) and Northstar Origin (Sept. 1) launches.

$BLLNMedAI 8/10

Billiontoone (BLLN) – Research Analysts’ Recent Ratings Updates

BillionToOne (NASDAQ: BLLN) saw multiple analyst rating and target changes. Weiss Ratings upgraded BLLN to “sell (d+)” (from “sell (d)”) on 5/15 and reaffirmed “sell (d)” on 5/1. Guggenheim raised its target to $120 (from $100) and kept a “buy” on 5/13. JPMorgan lifted its target to $125 and maintained “overweight” on 5/7. BTIG cut its target to $130 (from $140) while keeping “buy” on 5/7.